NYSEARCA:XPH SPDR S&P Pharmaceuticals ETF - XPH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. $43.42 -0.65 (-1.47%) (As of 02/8/2023 05:19 PM ET) Add Share Share Today's Range$43.36▼$43.8250-Day Range$40.06▼$44.2552-Week Range$37.94▼$46.61Volume84,845 shsAverage Volume39,475 shsMarket Capitalization$210.59 millionP/E RatioN/ADividend Yield1.55%Price TargetN/A ProfileChartInstitutional OwnershipHeadlinesOptions Chain Receive XPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive XPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer SSgA Fund NameSPDR S&P Pharmaceuticals ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:XPH Inception Date6/19/2006 Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson Webwww.spdrs.com Phone+1-617-6644738Fund Focus Asset ClassEquity BenchmarkS&P Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$211.41 million Average Daily Volume$39,320.00 Discount/Premium0.21% ETF Expenses Management Fee0.35% Other Expenses0.00% Total Expenses0.35% Fee Waiver0.00% Net Expenses0.35%Administrator, Advisor and Custodian AdministratorSSgA Funds Management, Inc. AdvisorSSgA Funds Management, Inc. CustodianState Street Bank and Trust Company DistributorState Street Global Advisors Funds Distributors, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerCitadel Geographic Exposure of XPHCurrency Exposure of XPHSector Exposure of XPHIndustry Exposure of XPH Key ExecutivesJames E. Ross (Age 52)President, Trustee Peter A. Ambrosini (Age 69)Chief Compliance Officer Michael P. Riley (Age 44)Vice President Gary L. French (Age 64)Treasurer John W. Clark (Age 46)Assistant Treasurer Matthew W. Flaherty (Age 42)Assistant Treasurer Chad C. Hallett (Age 47)Assistant Treasurer of Street tracks series trust Mary Moran Zeven (Age 52)Secretary Scott M. Zoltowski (Age 44)Assistant Secretary Dave KellyIndependent TrusteeMore ExecutivesInsiders & InstitutionsNwam LLCBought 340 shares on 2/8/2023Ownership: 0.247%LPL Financial LLCSold 18,141 shares on 2/7/2023Ownership: 2.051%Lionsbridge Wealth Management LLCBought 10,217 shares on 2/7/2023Ownership: 0.767%Envestnet Asset Management Inc.Bought 439 shares on 2/7/2023Ownership: 0.618%Commonwealth Equity Services LLCSold 363 shares on 2/7/2023Ownership: 0.109%View All Institutional Transactions XPH Stock - Frequently Asked Questions How have XPH shares performed in 2023? SPDR S&P Pharmaceuticals ETF's stock was trading at $40.95 on January 1st, 2023. Since then, XPH shares have increased by 6.7% and is now trading at $43.70. View the best growth stocks for 2023 here. Is SPDR S&P Pharmaceuticals ETF a good dividend stock? SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) pays an annual dividend of $0.67 per share and currently has a dividend yield of 1.55%. Read our dividend analysis for XPH. What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Micron Technology (MU), Broadcom (AVGO), Chevron (CVX), DocuSign (DOCU), SPDR Gold Shares (GLD), International Business Machines (IBM), JPMorgan Chase & Co. (JPM) and AT&T (T). What is SPDR S&P Pharmaceuticals ETF's stock symbol? SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH." Who are SPDR S&P Pharmaceuticals ETF's major shareholders? SPDR S&P Pharmaceuticals ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include LPL Financial LLC (2.05%), Lionsbridge Wealth Management LLC (0.77%), First Citizens Bank & Trust Co. (0.73%), Envestnet Asset Management Inc. (0.62%), Bank of Montreal Can (0.36%) and AE Wealth Management LLC (0.34%). How do I buy shares of SPDR S&P Pharmaceuticals ETF? Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is SPDR S&P Pharmaceuticals ETF's stock price today? One share of XPH stock can currently be purchased for approximately $43.70. How much money does SPDR S&P Pharmaceuticals ETF make? SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) has a market capitalization of $211.95 million. How can I contact SPDR S&P Pharmaceuticals ETF? SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The official website for the company is www.spdrs.com. The company can be reached via phone at +1-617-6644738. This page (NYSEARCA:XPH) was last updated on 2/8/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.